Home › Hemoglobinopathies › New York
Hemoglobinopathies clinical trials in New York
4 studies for Hemoglobinopathies are looking for participants at sites in New York.
Cities in New York
The HOPE Biobank Resource (BMT CTN 2402 HOPE)
- Memorial Sloan Kettering Cancer Center, New York
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Aug 27, 2026 · NCT07227155Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RecruitingPhase 3
Ages 12 to 35 · All sexes · Updated Mar 23, 2026 · NCT05477563Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Up to age 21 · All sexes · Updated Mar 13, 2026 · NCT04644016A Long-term Follow-up Study in Patients Who Received BEAM-101
- Columbia University Irving Medical Center, New York
RecruitingObservational study
Ages 14 to 37 · All sexes · Updated Jan 28, 2026 · NCT07373639From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.